Co-Diagnostics, Inc. — Director's Dealing 2022

Jan 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2022-01-08

Reporting Person: MURPHY TED (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-08	Common Stock	A	12500.00	$0.00	Acquired	25000.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-08	Restricted Stock Units	$0.00	M	12500.00	Disposed		Common Stock (25000.00)	Direct

Footnotes

F1: Included in 37,500 restricted stock units awarded to the Reporting Person on January 8, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in three equal installments every twelve months commencing on January 8, 2021.